Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Antimalarial Activity of Human Group IIA Secreted Phospholipase A2 in Relation to Enzymatic Hydrolysis of Oxidized Lipoproteins.

Dacheux M, Sinou V, Payré C, Jeammet L, Parzy D, Grellier P, Deregnaucourt C, Lambeau G.

Infect Immun. 2019 Oct 18;87(11). pii: e00556-19. doi: 10.1128/IAI.00556-19. Print 2019 Nov.


Azetidine-Containing Alkaloids Produced by a Quorum-Sensing Regulated Nonribosomal Peptide Synthetase Pathway in Pseudomonas aeruginosa.

Hong Z, Bolard A, Giraud C, Prévost S, Genta-Jouve G, Deregnaucourt C, Häussler S, Jeannot K, Li Y.

Angew Chem Int Ed Engl. 2019 Mar 4;58(10):3178-3182. doi: 10.1002/anie.201809981. Epub 2019 Jan 14.


Deconjugated Bile Salts Produced by Extracellular Bile-Salt Hydrolase-Like Activities from the Probiotic Lactobacillus johnsonii La1 Inhibit Giardia duodenalis In vitro Growth.

Travers MA, Sow C, Zirah S, Deregnaucourt C, Chaouch S, Queiroz RM, Charneau S, Allain T, Florent I, Grellier P.

Front Microbiol. 2016 Sep 27;7:1453. eCollection 2016.


The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.

Ehrhardt K, Deregnaucourt C, Goetz AA, Tzanova T, Gallo V, Arese P, Pradines B, Adjalley SH, Bagrel D, Blandin S, Lanzer M, Davioud-Charvet E.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5146-58. doi: 10.1128/AAC.02975-15. Print 2016 Sep.


Synthesis of New 4-Aminoquinolines and Evaluation of Their In Vitro Activity against Chloroquine-Sensitive and Chloroquine-Resistant Plasmodium falciparum.

Rajapakse CS, Lisai M, Deregnaucourt C, Sinou V, Latour C, Roy D, Schrével J, Sánchez-Delgado RA.

PLoS One. 2015 Oct 16;10(10):e0140878. doi: 10.1371/journal.pone.0140878. eCollection 2015.


In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.

Guillaume C, Payré C, Jemel I, Jeammet L, Bezzine S, Naika GS, Bollinger J, Grellier P, Gelb MH, Schrével J, Lambeau G, Deregnaucourt C.

Infect Immun. 2015 Jun;83(6):2453-65. doi: 10.1128/IAI.02474-14. Epub 2015 Mar 30.


Indole alkaloids from Muntafara sessilifolia with antiplasmodial and cytotoxic activities.

Girardot M, Deregnaucourt C, Deville A, Dubost L, Joyeau R, Allorge L, Rasoanaivo P, Mambu L.

Phytochemistry. 2012 Jan;73(1):65-73. doi: 10.1016/j.phytochem.2011.09.012. Epub 2011 Oct 25.


Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites.

Müller T, Johann L, Jannack B, Brückner M, Lanfranchi DA, Bauer H, Sanchez C, Yardley V, Deregnaucourt C, Schrével J, Lanzer M, Schirmer RH, Davioud-Charvet E.

J Am Chem Soc. 2011 Aug 3;133(30):11557-71. doi: 10.1021/ja201729z. Epub 2011 Jul 12.


Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine.

Rajapakse CS, Martínez A, Naoulou B, Jarzecki AA, Suárez L, Deregnaucourt C, Sinou V, Schrével J, Musi E, Ambrosini G, Schwartz GK, Sánchez-Delgado RA.

Inorg Chem. 2009 Feb 2;48(3):1122-31. doi: 10.1021/ic802220w.


Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity.

Rouault M, Rash LD, Escoubas P, Boilard E, Bollinger J, Lomonte B, Maurin T, Guillaume C, Canaan S, Deregnaucourt C, Schrével J, Doglio A, Gutiérrez JM, Lazdunski M, Gelb MH, Lambeau G.

Biochemistry. 2006 May 9;45(18):5800-16.


Interplay between lipoproteins and bee venom phospholipase A2 in relation to their anti-Plasmodium toxicity.

Guillaume C, Calzada C, Lagarde M, Schrével J, Deregnaucourt C.

J Lipid Res. 2006 Jul;47(7):1493-506. Epub 2006 Apr 10.


Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei.

Choi SJ, Parent R, Guillaume C, Deregnaucourt C, Delarbre C, Ojcius DM, Montagne JJ, Célérier ML, Phelipot A, Amiche M, Molgo J, Camadro JM, Guette C.

FEBS Lett. 2004 Aug 13;572(1-3):109-17.


Anti-Plasmodium properties of group IA, IB, IIA and III secreted phospholipases A2 are serum-dependent.

Guillaume C, Deregnaucourt C, Clavey V, Schrével J.

Toxicon. 2004 Mar 1;43(3):311-8.


Structural genomics of highly conserved microbial genes of unknown function in search of new antibacterial targets.

Abergel C, Coutard B, Byrne D, Chenivesse S, Claude JB, Deregnaucourt C, Fricaux T, Gianesini-Boutreux C, Jeudy S, Lebrun R, Maza C, Notredame C, Poirot O, Suhre K, Varagnol M, Claverie JM.

J Struct Funct Genomics. 2003;4(2-3):141-57.


Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton.

Le Bonniec S, Deregnaucourt C, Redeker V, Banerjee R, Grellier P, Goldberg DE, Schrével J.

J Biol Chem. 1999 May 14;274(20):14218-23.


Human erythroid spectrin alpha subunit and its SH3 domain are sensitive to acidic Plasmodium falciparum proteolytic activity.

Le Bonniec SL, Fournier C, Deregnaucourt C, Grellier P, Dhermy D, Lecomte MC, Schrevel J.

C R Acad Sci III. 1996 Nov;319(11):1011-7.


Turnover of the GPI-anchored surface antigen in Paramecium: Partial release of its acylated form into the culture medium.

Deregnaucourt C.

Eur J Protistol. 1992 May 22;28(2):220-5. doi: 10.1016/S0932-4739(11)80051-9. Epub 2011 Nov 4.


The membrane-anchor of Paramecium temperature-specific surface antigens is a glycosylinositol phospholipid.

Capdeville Y, Cardoso de Almeida ML, Deregnaucourt C.

Biochem Biophys Res Commun. 1987 Sep 30;147(3):1219-25.


Immunological evidence of a common structure between Paramecium surface antigens and Trypanosoma variant surface glycoproteins.

Capceville Y, Baltz T, Deregnaucourt C, Keller AM.

Exp Cell Res. 1986 Nov;167(1):75-86. Erratum in: Exp Cell Res 1987 Sep;172(1):following 242.


Surface antigens of Paramecium primaurelia. Membrane-bound and soluble forms.

Capdeville Y, Deregnaucourt C, Keller AM.

Exp Cell Res. 1985 Dec;161(2):495-508.


Supplemental Content

Loading ...
Support Center